Jeong-Han Kang Selected Research

Therapeutics

1/2020	IPF pathogenesis is dependent upon TGFβ induction of IGF-1.
4/2010	Efficacy of low dose barbiturate coma therapy for the patients with intractable intracranial hypertension using the bispectral index monitoring.
10/2009	Comparative proteome analysis of TGF-beta1-induced fibrosis processes in normal rat kidney interstitial fibroblast cells in response to ascofuranone.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jeong-Han Kang Research Topics

Disease

8	Fibrosis (Cirrhosis) 01/2020 - 05/2009
4	Neoplasms (Cancer) 01/2020 - 04/2012
3	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2020 - 06/2017
2	Pain (Aches) 05/2013 - 01/2011
1	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2020
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2019
1	Idiopathic Pulmonary Fibrosis 11/2016
1	Inflammation (Inflammations) 06/2014
1	Breast Neoplasms (Breast Cancer) 06/2014
1	Rheumatoid Arthritis 05/2013
1	Atherosclerosis 05/2013
1	Chronic Disease (Chronic Diseases) 01/2013
1	Hemifacial Spasm 08/2012
1	Vertebrobasilar Insufficiency 08/2012
1	Carcinoma (Carcinomatosis) 04/2012
1	Hypoxia (Hypoxemia) 04/2012
1	Starvation 04/2011
1	Tremor (Tremors) 01/2011
1	Parkinson Disease (Parkinson's Disease) 01/2011
1	Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive) 01/2011
1	Intracranial Hypertension 04/2010
1	Coma (Comas) 04/2010
1	Thrombosis (Thrombus) 10/2009

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 01/2020 - 10/2009
4	Transforming Growth Factor beta (TGF-beta)IBA 01/2020 - 05/2009
3	Bleomycin (Blenoxane)FDA LinkGeneric 01/2020 - 11/2016
3	Melitten (Melittin)IBA 06/2014 - 05/2013
2	Fibronectins (Fibronectin)IBA 12/2019 - 01/2014
2	Peptides (Polypeptides)IBA 06/2017 - 06/2014
2	Bee Venoms (Bee Venom)IBA 06/2014 - 05/2013
2	Epidermal Growth Factor (EGF)IBA 06/2014 - 04/2012
2	Plasminogen Activator Inhibitor 1IBA 01/2014 - 10/2009
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 04/2012 - 04/2012
2	ProteomeIBA 04/2011 - 10/2009
1	CB-839IBA 01/2020
1	3- (8- amino- 1- (2- phenylquinolin- 7- yl)imidazo(1,5- a)pyrazin- 3- yl)- 1- methylcyclobutanolIBA 01/2020
1	Insulin-Like Growth Factor I (IGF-1)IBA 01/2020
1	Insulin (Novolin)FDA Link 01/2020
1	Glutamine (L-Glutamine)FDA Link 01/2020
1	GlutaminaseIBA 01/2020
1	Connective Tissue Growth FactorIBA 12/2019
1	lonidamineIBA 12/2019
1	indium-bleomycinIBA 01/2018
1	AcidsIBA 06/2017
1	Biological ProductsIBA 06/2014
1	ApaminIBA 06/2014
1	Collagen Type I (Type I Collagen)IBA 01/2014
1	Pharmaceutical PreparationsIBA 01/2014
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2013
1	Interleukin-33IBA 01/2013
1	matrigelIBA 04/2012
1	cobaltous chloride (cobalt(II)chloride)IBA 04/2012
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2012
1	ascochlorinIBA 04/2012
1	MetalsIBA 04/2012
1	70-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 70 kDa)IBA 04/2012
1	Small Interfering RNA (siRNA)IBA 04/2011
1	Messenger RNA (mRNA)IBA 04/2011
1	Annexin A1IBA 04/2011
1	barbituric acid (barbiturate)IBA 04/2010
1	ascofuranoneIBA 10/2009
1	Transforming Growth Factors (Transforming Growth Factor)IBA 05/2009
1	CytokinesIBA 05/2009
1	Plasminogen InactivatorsIBA 05/2009
1	A-factor (Streptomyces)IBA 05/2009

Therapy/Procedure

3	Therapeutics 01/2020 - 10/2009
1	Microvascular Decompression Surgery 08/2012
1	Spinal Cord Stimulation 01/2011